4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-22-027264
Options or other derivatives
- Chief Commercial Officer acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Deardorf Caren Chief Commercial Officer | 2022-08-01 | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | D | ||
Loading xslF345X03/doc4.xml…